Three cases of severe hypotension associated with the use of angiotensin-converting enzyme inhibitors (ACEIs) and intravenous administration of the synthetic colloid Gelofusin (Braun Medical Ltd) are presented. A possible mechanism of interaction between ACEIs and Gelofusin is discussed. All three patients were treated successfully.
CosterousseO., JaspardE., WeiL., CorvolP., Alhenc-GelasF.The angiotensin I converting enzyme (kininase II): molecular organisation and regulation of its expression in humans.J Cardiovasc Pharmacol1992; 20(Suppl 9): S10–S15.
2.
BonnerG., PreisS., SchunkU., WagmannM., ChroschR., ToussaintC.Effect of bradykinin on arteries and veins in systemic and pulmonary circulation.J Cardiovasc Pharmacol1992; 20(Suppl 9): S21–S27.
3.
MombouliJ.V., VanhoutteP.M.Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: Role of bradykinin generation during ACE inhibition.J Cardiovasc Pharmacol1992; 20(Suppl 9): S74–S83.
4.
SchrorK.Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors.J Cardiovasc Pharmacol1992; 20(Suppl 9): S68–S73.
5.
OwenH.G., BrecherM.E.Atypical reactions associated with the use of angiotensin-converting enzyme inhibitors and apheresis.Transfusion1994; 34(10): 891–894.
